ProfileGDS4132 / 235289_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 31% 32% 32% 29% 34% 34% 32% 37% 29% 32% 33% 22% 30% 32% 35% 29% 37% 28% 32% 33% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10175.97631
GSM201543Muscle PCOS pioglitazone 12171.36732
GSM201544Muscle PCOS pioglitazone 16181.197332
GSM201545Muscle PCOS pioglitazone 20179.098629
GSM201829Muscle PCOS pioglitazone 23192.274734
GSM201830Muscle PCOS pioglitazon 25187.278334
GSM201831Muscle PCOS pioglitazone 27176.91832
GSM201832Muscle PCOS pioglitazone 3195.459637
GSM201833Muscle PCOS pioglitazone 4166.346929
GSM201834Muscle PCOS pioglitazone 8176.67432
GSM201835Muscle PCOS after pioglitazone 10268.805833
GSM201836Muscle PCOS after pioglitazone 12242.104522
GSM201837Muscle PCOS after pioglitazone 16259.190530
GSM201838Muscle PCOS after pioglitazone 20270.973232
GSM201839Muscle PCOS after pioglitazone 23282.698135
GSM201840Muscle PCOS after pioglitazone 25267.407929
GSM201841Muscle PCOS after pioglitazone 27279.368137
GSM201842Muscle PCOS after pioglitazone 3252.914928
GSM201843Muscle PCOS after pioglitazone 4278.803632
GSM201844Muscle PCOS after pioglitazone 8275.745233